Search
01/01/2022
Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study
Batista, G, Marin-Jimenez, I, Fores, A, Garcia-Planella, E, Arguelles-Arias, F, Tagarro, I, Fernandez-Nistal, A, Montoto, C, Aparicio, J, Aguas, M, Santos-Fernandez, J, Bosca-Watts, MM, Ferreiro-Iglesias, R, Merino, O, Aldeguer, X, Corttes, X, Sicilia, B, Mesonero, F, Barreiro-de Acosta, M. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study. DIGESTIVE AND LIVER DISEASE. 2022; 54(1)DOI:10.1016/j.dld.2021.06.005. PMID:34244110. IF:4.500(Q2/4D).
01/01/2022
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Zabana, Y, Marin-Jimenez, I, Rodriguez-Lago, I, Vera, I, Martin-Arranz, MD, Guerra, I, Gisbert, JP, Mesonero, F, Benitez, O, Taxonera, C, Ponferrada-Diaz, A, Piqueras, M, Lucendo, AJ, Caballol, B, Manosa, M, Martinez-Montiel, P, Bosca-Watts, M, Gordillo, J, Bujanda, L, Mancenido, N, Martinez-Perez, T, Lopez, A, Rodriguez-Gutierrez, C, Garcia-Lopez, S, Vega, P, Rivero, M, Melcarne, L, Calvo, M, Iborra, M, de-Acosta, MB, Sicilia, B, Barrio, J, Perez, JL, Busquets, D, Perez-Martinez, I, Navarro-Llavat, M, Hernandez, V, Argueelles-Arias, F, Esteso, FR, Meijide, S, Ramos, L, Gomollon, F, Munoz, F, Suris, G, de Zarate, JO, Huguet, JM, Llao, J, Garcia-Sepulcre, MF, Sierra, M, Dura, M, Estrecha, S, Coronel, AF, Hinojosa, E, Olivan, L, Iglesias, E, Gutierrez, A, Varela, P, Rull, N, Gilabert, P, Hernandez-Camba, A, Brotons, A, Ginard, D, Sese, E, Carpio, D, Aceituno, M, Cabriada, JL, Gonzalez-Lama, Y, Jimenez, L, Chaparro, M, Roman, ALS, Alba, C, Plaza-Santos, R, Mena, R, Tamarit-Sebastian, S, Ricart, E, Calafat, M, Olivares, S, Navarro, P, Bertoletti, F, Alonso-Galan, H, Pajares, R, Olcina, P, Manzano, P, Domenech, E, Esteve, M. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry. Journal of Clinical Medicine. 2022; 11(2)DOI:10.3390/jcm11020421. PMID:35054116. IF:3.900(Q2/4D).
01/01/2022
Non-invasive tests for clinically significant portal hypertension after HCV cure
Semmler G., Lens S., Meyer E.L., Baiges A., Alvardo-Tapias E., Llop E., Tellez L., Schwabl P., Mauro E., Escudé L., Díez C., Ibañez-Samaniego L., Puente Á., Fortea J.I., Abadía M., Zanetto A., Conthe A., Hernandez-Évole H., Luzko Scheid I.S., Jia J., Yoshiji H., Francque S.M., Tsochatzis E.A., Russo F.P., Crespo G., Forns X., Bañares R., Villanueva C., Hernández-Gea V., Reiberger T., Bosch J., García Pagán J.C., Mandorfer M.. Non-invasive tests for clinically significant portal hypertension after HCV cure. JOURNAL OF HEPATOLOGY. 2022; 77(6)DOI:10.1016/j.jhep.2022.08.025. PMID:36063968. IF:25.700(Q1/1D).
01/01/2022
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease
Iborra M., Moret I., Busó E., García-Giménez J.L., Ricart E., Gisbert J.P., Cabré E., Esteve M., Márquez-Mosquera L., García-Planella E., Guardiola J., Pallardó F.V., Serena C., Algaba-Chueca F., Domenech E., Nos P., Beltrán B.. The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn’s Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(24)DOI:10.3390/ijms232415881. PMID:36555526. IF:5.600(Q1/3D).
01/01/2022
EUS-guided gastroenterostomy versus duodenal self-expandable metal stent for malignant gastric outlet obstruction: results from a nationwide multicenter retrospective study (with video)
Sánchez-Aldehuelo R., Subtil Iñigo J.C., Martínez Moreno B., Gornals J., Guarner-Argente C., Repiso Ortega A., Peralta Herce S., Aparicio J.R., Rodríguez de Santiago E., Bazaga S., Juzgado D., González-Panizo F., Albillos A., Vázquez-Sequeiros E.. EUS-guided gastroenterostomy versus duodenal self-expandable metal stent for malignant gastric outlet obstruction: results from a nationwide multicenter retrospective study (with video). GASTROINTESTINAL ENDOSCOPY. 2022; 96(6)DOI:10.1016/j.gie.2022.07.018. PMID:35870508. IF:7.700(Q1/2D).
01/01/2022
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gallego-Durán R., Albillos A., Ampuero J., Arechederra M., Bañares R., Blas-García A., Berná G., Caparrós E., Delgado T.C., Falcón-Pérez J.M., Francés R., Fernández-Barrena M.G., Graupera I., Iruzubieta P., Nevzorova Y.A., Nogueiras R., Macías R.I.R., Martín F., Sabio G., Soriano G., Vaquero J., Cubero F.J., Gracia-Sancho J.. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterologia y Hepatologia. 2022; 45(9)DOI:10.1016/j.gastrohep.2022.02.005. PMID:35248669. IF:1.900(Q4/10D).